Dearborn Partners LLC Novo Nordisk A S Transaction History
Dearborn Partners LLC
- $2.35 Billion
- Q4 2024
A detailed history of Dearborn Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dearborn Partners LLC holds 3,972 shares of NVO stock, worth $275,815. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,972
Previous 3,572
11.2%
Holding current value
$275,815
Previous $425,000
19.76%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,887Shares Held
335MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.38 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.08 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$902 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$878 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$847 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $157B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...